News

The “CT first” strategy was associated with subsequent revascularization in 62% of patients compared to 34% for the combination of other modalities or direct ICA referral.

In the survey, only 49% of people named heart disease as the leading cause of death; 16% said they didn't know the leading cause and 18% listed cancer as the top cause of death of people in the U.S.

Philips has developed the smaller X11 4t Mini 3D TEE transducer to serve more patients with this valuable imaging tool, from pediatric patients to older adults and everyone in between.

Cook Medical announced the first patient treated in the clinical study of the ZENITH® FENESTRATED+ Endovascular Graft (ZFEN+) in the United States.

While the 30-day mortality rates were similar (0.2% for SAVR vs. 0.4% for TAVR), the 5-year survival rate was significantly better after surgery compared to TAVR (98% vs. 86%, p < 0.001). For secondary outcomes, there was no significant...

Looking at trends each year from 2010 to 2022, the researchers’ findings show that the death rates from cardiovascular disease rose by 9.3% from 2020 through 2022, in contrast to a decline of 8.9% from 2010 to 2019.

MOUNTAIN VIEW, Calif. – HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care solutions, announced FFRCT&nbsp;was transitioned to a Category I Current Procedural Terminology (CPT®) code beginning January...

Trial to randomize 400 subjects at multiple sites, primarily in the U.S., to evaluate safety and efficacy of the investigational Nectero EAST System for treatment of infrarenal AAA, maximum diameter 3.5-5.0cm TEMPE, Ariz., January 18,...

The company's peripheral IVL technology offers a user-friendly design with a highly deliverable, low-profile, rupture-resistant balloon that generates durable and predictable circumferential ultrasonic pressure.